PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 207 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $94,000 | -61.5% | 13,114 | +28.4% | 0.01% | 0.0% |
Q4 2019 | $244,000 | -92.8% | 10,211 | -92.0% | 0.01% | -94.0% |
Q3 2019 | $3,405,000 | +23.5% | 126,965 | +25.0% | 0.10% | +3.1% |
Q2 2019 | $2,757,000 | -67.3% | 101,600 | -58.2% | 0.10% | -66.9% |
Q1 2019 | $8,442,000 | +295.4% | 243,290 | +122.4% | 0.29% | +257.3% |
Q4 2018 | $2,135,000 | +38.9% | 109,400 | +89.6% | 0.08% | +20.6% |
Q3 2018 | $1,537,000 | +62.1% | 57,700 | +129.9% | 0.07% | +33.3% |
Q2 2018 | $948,000 | +110.2% | 25,100 | +170.5% | 0.05% | +37.8% |
Q4 2017 | $451,000 | -61.7% | 9,279 | -55.8% | 0.04% | -69.7% |
Q2 2017 | $1,179,000 | +313.7% | 20,990 | +74.3% | 0.12% | +90.6% |
Q2 2016 | $285,000 | – | 12,043 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 228,873 | $7,475,000 | 4.17% |
PFM Health Sciences, LP | 5,326,671 | $173,969,000 | 3.54% |
Marcus Capital, LLC | 22,950 | $750,000 | 2.76% |
Partner Investment Management, L.P. | 72,284 | $2,361,000 | 2.55% |
CADIAN CAPITAL MANAGEMENT, LP | 1,240,944 | $40,529,000 | 2.19% |
HARVEY CAPITAL MANAGEMENT INC | 158,580 | $5,179,000 | 1.94% |
SECTORAL ASSET MANAGEMENT INC | 498,412 | $16,278,000 | 1.78% |
Everett Capital Advisors UK LLP | 551,173 | $18,001,000 | 1.52% |
ROSENBLUM SILVERMAN SUTTON S F INC /CA | 125,210 | $4,089,000 | 1.46% |
Atika Capital Management LLC | 113,000 | $3,691,000 | 1.26% |